Tilray Brands (TLRY) EBITDA Margin (QoQ) (2017 - 2026)
Tilray Brands (TLRY) EBITDA Margin (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Tilray Brands | - | - | 54.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 273.00 |
| Nov 30, 2025 | -1,858.00 |
| Aug 31, 2025 | 56,297.00 |
| May 31, 2025 | -13,230.00 |
| Feb 28, 2025 | -38,536.00 |
| Nov 30, 2024 | -2,943.00 |
| Aug 31, 2024 | 153.00 |
| May 31, 2024 | 4,146.00 |
| Feb 29, 2024 | -3,709.00 |
| Nov 30, 2023 | 861.00 |
| Aug 31, 2023 | 5,277.00 |
| May 31, 2023 | 66,787.00 |
| Feb 28, 2023 | -67,833.00 |
| Nov 30, 2022 | 1,188.00 |
| Aug 31, 2022 | 23,149.00 |
| May 31, 2022 | -33,629.00 |
| Feb 28, 2022 | 4,849.00 |
| Nov 30, 2021 | 5,332.00 |
| Aug 31, 2021 | -24,368.00 |
| May 31, 2021 | 38,942.00 |